T1	p 21 47	autism spectrum disorder :
T2	p 308 447	autism spectrum disorder ( ASD ) symptoms in children and adolescents with both ASD and attention-deficit/hyperactivity disorder ( ADHD ) .
T3	p 456 516	A total of 97 patients 6-17 years of age , with ASD and ADHD
T4	i 6 17	Atomoxetine
T5	i 293 304	atomoxetine
T6	i 554 572	atomoxetine during
T7	i 583 621	double-blind placebo-controlled period
T8	i 843 881	treatment , atomoxetine administration
T9	i 1163 1188	However , atomoxetine may
T10	o 62 82	social functioning ;
T11	o 110 154	stereotyped behaviors , inappropriate speech
T12	o 161 177	fear of change .
T13	o 704 804	the Aberrant Behavior Checklist ( ABC ) and the Children 's Social Behavior Questionnaire ( CSBQ ) .
T14	o 935 1062	the ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior , and on the CSBQ subscale Fear for Changes .
T15	o 1142 1162	social functioning .
T16	o 1211 1256	and stereotyped behaviors and communication .